(Q24338709)

GOA release 2020-03-11

cellular response to pH

1 reference

The evolving role of statins in the management of atherosclerosis

GOA release 2020-03-11

1 reference

Mark A Deeg

1

0 references

Nandita S Raikwar

series ordinal

2

0 references

Cynthia Johnson

series ordinal

3

0 references

Craig D Williams

series ordinal

4

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

Translational Research

0 references

volume

150

0 references

page(s)

153-7

0 references

issue

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Stroke prevention, blood cholesterol, and statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Glycosylphosphatidylinositol-specific phospholipase D in blood serum: is the liver the only source of the enzyme?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Glycosyl phosphatidyl inositol phospholipase D activity in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Inositol-specific phospholipase D activity in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Enzymatic properties of phosphatidylinositol-glycan-specific phospholipase C from rat liver and phosphatidylinositol-glycan-specific phospholipase D from rat serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

High-density lipoprotein subpopulations in pathologic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008

Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.008